Could common immune drugs slow Parkinson's?
NCT ID NCT06834191
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study looks at whether long-term use of immunosuppressive drugs (taken for other conditions) can slow the onset or progression of Parkinson's disease. Researchers will compare 80 people with Parkinson's—half on immunosuppressants, half not—by tracking motor symptoms and inflammatory markers. Participants attend one hour-long visit for assessments, questionnaires, and a blood sample.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Neurology, Faculty of Health Science, Medical University of Warsaw
RECRUITINGWarsaw, 02-091, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Planning ahead: could a simple program transform Parkinson's care?
- Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
- Could a brain disease change behavior years before diagnosis?